The Impact of Obesity and Nutrition on Chronic Liver Diseases An Issue of Clinics in Liver Disease 1st Edition at Meripustak

The Impact of Obesity and Nutrition on Chronic Liver Diseases An Issue of Clinics in Liver Disease 1st Edition

Books from same Author: Younossi, Zobair

Books from same Publisher: Elseiver

Related Category: Author List / Publisher List


  • Retail Price: ₹ 8929/- [ 5.00% off ]

    Seller Price: ₹ 8482

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Younossi, Zobair
    PublisherElseiver
    Edition1st Edition
    ISBN9780323266642
    Pages280
    LanguageEnglish
    Publish YearJanuary 2014

    Description

    Elseiver The Impact of Obesity and Nutrition on Chronic Liver Diseases An Issue of Clinics in Liver Disease 1st Edition by Younossi, Zobair

    Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue. In the first article, the epidemiology of obesity and its association with liver disease are covered. The following two articles focus on the roles that visceral adipose tissue and microbiota potentially play in the pathogenesis of obesity-related liver disease. The next article focuses on the hepatic pathology seen in patients with obesity-related liver disease and those with malnutrition. The next five articles are focused on NAFLD and provide in-depth data on the natural history and treatment strategies for patients with NAFLD. The next six articles deal with the impact of obesity on other liver diseases and on special populations including children and liver-transplant recipients. The final article provides the most updated information regarding genomics and genetic targets that may provide better prognostic and diagnostic biomarkers and more personalized treatment targets for patients with NAFLD. Cutting-edge information in this issue will help readers gain better understanding of the natural history and pathogenesis of primary and secondary liver diseases associated with obesity. As the information about obesity-related liver disease expands, clinicians will be able to provide more targeted therapeutic options for these patients and develop more accurate diagnostic and prognostic biomarkers._x000D_